Metatron Capital SICAV’s Cigna CI Stock Holding History

Metatron Capital SICAV’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$1.01M	Buy	+4,400	New	+$935K	0.96%	24

Other funds holding CI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Metatron Capital SICAV's CI Position: Q4 2021 in Review

Metatron Capital SICAV opened a new position in Cigna (CI) in Q4 2021: 4,400 shares worth $1.01M. The stake represents 0.96% of the portfolio and ranks #24 among its holdings.

1,331 funds tracked by Wall St. Rank hold CI as of Q4 2021.

Metatron Capital SICAV held 4,400 shares of Cigna worth $1.01M as of Q4 2021.
Cigna was a new Metatron Capital SICAV position in Q4 2021.
Cigna made up 0.96% of Metatron Capital SICAV's portfolio in Q4 2021, its #24 holding.
1,331 funds tracked by Wall St. Rank held Cigna as of Q4 2021.

Based on Metatron Capital SICAV's 13F filing for Q4 2021, filed 15 Feb 2022.